首頁 > 市場調查報告書 > 食物/飲料

機能性食品

市場調查報告書

商品編碼

1654731

全球植物雌激素補充劑市場 - 2025 至 2033 年

Global Phytoestrogen Supplements Market - 2025-2033

出版日期: 2025年02月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球植物雌激素補充劑市場規模達到 357 萬美元，預計到 2033 年將達到 511 萬美元，在 2025-2033 年預測期內的複合年成長率為 4.6%。

全球植物雌激素補充劑市場包括含有植物雌激素的膳食補充劑市場，這些植物雌激素是模擬人體內雌激素的植物衍生化合物。這些補充劑主要用於緩解與荷爾蒙變化相關的症狀，尤其是在更年期，並支持女性的整體健康。

隨著消費者對女性健康問題的認知不斷提高以及對治療更年期相關症狀的自然療法的需求，全球植物雌激素補充劑市場有望大幅擴張。由於擁有適用於多種應用的多種產品，該市場為旨在滿足注重健康的消費者的製造商和供應商提供了大量機會。

市場動態：

促進因素與約束因素

對荷爾蒙替代療法 (HRT) 的天然替代品的需求不斷增加

對荷爾蒙替代療法 (HRT) 的天然替代品的需求不斷增加，這是全球植物雌激素補充劑市場發展的重要推動力。這一趨勢反映了消費者，特別是更年期女性，越來越傾向於選擇更安全、更自然的方式來控制荷爾蒙變化和相關症狀。

傳統的荷爾蒙替代療法可以有效緩解潮熱和情緒波動等更年期症狀。然而，它通常與潛在的健康風險有關，包括增加乳癌、心臟病和血栓的風險。隨著對這些風險的認知不斷提高，許多女性正在尋求既能提供類似益處又不會帶來相關危險的替代品。

社會正在越來越廣泛地轉向自然和整體的健康解決方案。消費者對源自植物等天然來源的膳食補充劑越來越感興趣，因為它們被認為更安全、更符合健康的生活方式。植物雌激素存在於大豆、亞麻籽和扁豆等各種植物性食物中，可作為合成荷爾蒙的植物替代品。

此外，產業投資和研發的關鍵參與者將推動全球植物雌激素補充劑市場的擴張。例如，2023 年 10 月，總部位於圖森的新創公司 NeuTherapeutics 從美國國立衛生研究院 (NIH)，特別是美國國家老化研究所 (NIA) 獲得了 250 萬美元的資助。這筆資金將用於支持第二階段臨床試驗，旨在評估 PhytoSERM 的有效性，PhytoSERM 是一種旨在緩解更年期女性潮熱的膳食補充劑。所有這些因素都要求全球植物雌激素補充劑市場的發展。

此外，2023年12月，選擇性雌激素B受體植物雌激素製劑PhytoSERM的開發旨在解決女性的兩個重大健康問題：降低阿茲海默症的風險和緩解更年期症狀。目前正在透過第二階段隨機臨床試驗框架來探索該計劃。此外，對功能性食品和飲料監測成長的需求不斷成長，促進了全球植物雌激素補充劑市場的擴張。

副作用的風險

與植物雌激素補充劑相關的副作用風險代表了全球植物雌激素補充劑市場面臨的重大限制。儘管作為荷爾蒙替代療法 (HRT) 的天然替代品，植物雌激素越來越受歡迎，但對安全性和潛在副作用的擔憂可能會削弱消費者信心並阻礙市場成長。這些不良反應可能會阻止消費者持續使用這些產品，從而限制市場擴張。

一項統合分析表明，植物雌激素補充劑與腹部不適和噁心等胃腸道副作用的發生率中度升高有關。這些問題可能會導致一些人停止使用，從而引起擔心消化健康的潛在用戶的猶豫。

The global phytoestrogen supplements market encompasses the market for dietary supplements containing phytoestrogens plant-derived compounds that mimic estrogen in the body. These supplements are primarily used to alleviate symptoms related to hormonal changes, especially during menopause, and to support overall women's health.

The global phytoestrogen supplements market is poised for significant expansion due to increasing consumer awareness of women's health issues and the demand for natural remedies for menopause-related symptoms. With a diverse range of products available across multiple applications, this market presents numerous opportunities for manufacturers and suppliers aiming to cater to health-conscious consumers.These factors have driven the global phytoestrogen supplements market expansion.

Market Dynamics: Drivers & Restraints

Increasing Demand for Natural Alternatives to Hormone Replacement Therapy (HRT)

The increasing demand for natural alternatives to hormone replacement therapy (HRT) is a significant driver in the global phytoestrogen supplements market. This trend reflects a growing preference among consumers, particularly women experiencing menopause, for safer and more natural options to manage hormonal changes and associated symptoms.

Traditional hormone replacement therapy has been effective in alleviating menopausal symptoms, such as hot flashes and mood swings. However, it is often linked to potential health risks, including an elevated risk of breast cancer, heart disease, and blood clots. As awareness of these risks increases, many women are seeking alternatives that provide similar benefits without the associated dangers.

There is a broader societal shift towards natural and holistic health solutions. Consumers are increasingly interested in dietary supplements derived from natural sources, such as plants, which are perceived as safer and more aligned with a healthy lifestyle. Phytoestrogens, found in various plant-based foods like soy, flaxseeds, and lentils, offer a plant-derived alternative to synthetic hormones.

Furthermore, key players in the industry investments and research & developments that would drive the global phytoestrogen supplements market expansion. For instance, in October 2023, NeuTherapeutics, a startup based in Tucson, secured a $2.5 million grant from the National Institutes of Health (NIH), specifically from the National Institute on Aging (NIA). This funding will support a Phase 2 clinical trial aimed at evaluating the effectiveness of PhytoSERM, a dietary supplement designed to alleviate hot flashes in menopausal women. All these factors demand the global phytoestrogen supplements market.

Also, in December 2023, the development of PhytoSERM, a selective estrogen B-receptor phytoestrogen formulation, aims to tackle two significant health issues for women: reducing the risk of Alzheimer's disease and alleviating menopausal symptoms. This initiative is currently being explored through a Phase 2 randomized clinical trial framework. Moreover, the rising demand for the growth of growth in functional foods and beverages monitoring contributes to the global phytoestrogen supplements market expansion.

Risks of Side Effects

The risks of side effects associated with phytoestrogen supplements represent significant constraints within the global phytoestrogen supplements market. Despite their increasing popularity as natural alternatives to hormone replacement therapy (HRT), concerns about safety and potential adverse effects can undermine consumer confidence and hinder market growth.Phytoestrogens can cause various side effects, including allergic reactions, abdominal pain, muscle pain (myalgia), and sleepiness. Such adverse reactions may discourage consumers from consistently using these products, which could limit market expansion.

A meta-analysis has shown that phytoestrogen supplements are linked to moderately elevated rates of gastrointestinal side effects, such as abdominal discomfort and nausea. These issues can lead some individuals to discontinue use, creating hesitance among potential users who are concerned about their digestive health.Thus, the above factors could be limiting the global phytoestrogen supplements market's potential growth.

Segment Analysis

The global phytoestrogen supplements market is segmented based on type, source, application, end-user, and region.

Type:

The flavonoids segment is expected to dominate the global phytoestrogen supplements market share

The flavonoids segment holds a major portion of the global phytoestrogen supplements market share and is expected to continue to hold a significant portion of the global phytoestrogen supplements market share during the forecast period. The flavonoids segment within the global phytoestrogen supplements market is essential due to the unique properties and health benefits associated with flavonoids, which are a subclass of phytoestrogens. This segment is anticipated to witness significant growth as consumer awareness of the benefits of phytoestrogens increases, particularly in managing menopausal symptoms and enhancing overall health.

Flavonoids are plant-derived compounds known for their antioxidant properties and ability to mimic estrogen in the body. They can be categorized into several types, including isoflavones (such as daidzein, genistein, glycitein, and biochanin A) and coumestans. Each type has distinct biological activities and health benefits, making them valuable in dietary supplements targeted at women's health. Flavonoids are particularly recognized for their potential to alleviate menopausal symptoms, including hot flashes, mood swings, and night sweats. They also contribute to cardiovascular health, support bone density maintenance, and help achieve overall hormonal balance. This makes flavonoids appealing to women seeking natural alternatives to hormone replacement therapy (HRT).

Furthermore, key players in the industry innovative launches that would drive this segment growth in the global phytoestrogen supplements market.For instance, in November 2023, Mena, launched is a new range of products that includes breads, breakfast cereals, and snack bars specifically designed to alleviate menopause symptoms. This innovative food line incorporates ingredients rich in plant estrogens, also known as phytoestrogens, which are believed to help reduce discomfort associated with menopause. By providing these phytoestrogen-rich options, Mena offers a natural food alternative for women seeking relief during this transitional phase of life.

Also, in August 2022, Vedistry launched Fortyfitt Woman Tablets, a dietary supplement specifically designed to assist women during the transition from perimenopause to menopause. These tablets feature a potent blend of soya phytoestrogens and various nutraceuticals, including green tea, ginseng, grape seed extract, and omega-3 fatty acids. These factors have solidified the segment's position in the global phytoestrogen supplements market.

Geographical Analysis

North America is expected to hold a significant position in the global phytoestrogen supplements market share

North America holds a substantial position in the global phytoestrogen supplements market and is expected to hold most of the market share. Consumers in North America are increasingly leaning towards natural and alternative health solutions. This trend is reflected in the rising consumption of dietary supplements that contain plant-derived compounds like phytoestrogens. Concerns about the side effects associated with synthetic medications have fueled this shift towards natural ingredients.

There is a heightened awareness among women regarding menopause and its associated symptoms. As more women seek relief from symptoms such as hot flashes, mood swings, and night sweats, the demand for phytoestrogen supplements has surged. These products are increasingly viewed as effective natural alternatives to hormone replacement therapy (HRT).

There has been substantial investment in research and development within the dietary supplement industry. Companies are focusing on creating innovative phytoestrogen products that cater to health-conscious consumers. This emphasis on R&D enhances product efficacy and safety, further propelling market growth.

There is an increasing trend towards nutraceuticals foods that provide health benefits beyond basic nutrition. Phytoestrogen supplements fit well within this category as they offer specific health benefits related to hormonal balance and menopausal symptom relief.

Furthermore, in this region, a major of key players presence, well-advanced healthcare infrastructure, and launches that would drive this global phytoestrogen supplements market growth. For instance, in August 2023, Designs for Health launched a new line of women's health supplements, featuring ProbioMed Women and FemGuard-HF. These products are specifically formulated to meet the unique health requirements of women throughout various life stages. Thus, the above factors are consolidating the region's position as a dominant force in the global phytoestrogen supplements market.

Asia Pacific is growing at the fastest pace in the global phytoestrogen supplements market share

Asia Pacific holds the fastest pace in the global phytoestrogen supplements market and is expected to hold most of the market share. There has been a significant rise in health awareness among consumers in the Asia-Pacific region. Many individuals are prioritizing their health and well-being, leading to increased demand for nutritional supplements, including phytoestrogens. This shift is fueled by a growing recognition of the importance of preventive healthcare, prompting consumers to seek solutions that enhance their overall health.

The region is witnessing a rapidly aging demographic, particularly in countries like Japan and China. As more individuals enter menopause, there is heightened demand for products that address age-related health issues, including hormonal imbalances. Phytoestrogen supplements are appealing because they provide natural alternatives to hormone replacement therapy (HRT) for managing menopausal symptoms.

Consumers are increasingly favoring natural and plant-based health solutions. Many are moving away from synthetic medications due to concerns about side effects and toxicity. This trend is driving demand for phytoestrogen supplements, which are derived from natural sources and perceived as safer options. The trend toward nutraceuticals-foods that provide health benefits beyond basic nutrition is gaining traction in the Asia-Pacific market. Phytoestrogens fit well within this category, offering specific benefits related to hormonal balance and relief from menopausal symptoms, thus appealing to health-conscious consumers.

Furthermore, in this region, a major of key players presence, well-advanced healthcare infrastructure, and launches that would drive this global phytoestrogen supplements market growth. For instance, in August 2022, Charak Pharma launched Fortyfitt Woman tablets, a dietary supplement specifically formulated to assist women during their transition from perimenopause to menopause. These tablets feature a potent blend of soya phytoestrogens and various nutraceuticals, including green tea, ginseng, grape seed extract, and omega-3 fatty acids. This combination aims to support overall health and well-being for women in their forties, addressing common menopausal symptoms effectively. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global phytoestrogen supplements market.

Competitive Landscape

The major global players in the phytoestrogen supplements market include DoTERRA, Nutra Green, NATURAL ORGANICS INC., Solaray, Archer Daniels Midland Company, Nature's Way Deltastar, and A.Vogel among others.

Key Developments

In August 2024, Life Extension introduced the Estrogen Balance Elite supplement. A recent survey conducted by the brand revealed that over 80% of women reported experiencing hormone-related discomfort at least once a week. This statistic highlights the commonality of issues such as hot flashes, night sweats, and mood swings, particularly during perimenopause and menopause.
In October 2022, PharmaLinea introduced an advanced whole-body menopause supplement named Your Meno Ease. This product is specifically formulated to alleviate a variety of symptoms associated with menopause, including pain, hot flashes, and mood swings. Clinical research has shown that Your Meno Ease can reduce pain intensity by 27% compared to a placebo, highlighting its effectiveness in managing menopausal symptoms.
In October 2022, Health & Her introduced a new line of menopause supplements that are specifically phytoestrogen-free, catering to women who wish to avoid plant-based estrogens in their dietary products. This decision addresses the growing awareness and concerns among women regarding hormone-related issues during menopause.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global phytoestrogen supplements market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Source
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Demand for Natural Alternatives to Hormone Replacement Therapy (HRT)
- 4.1.2. Restraints
  - 4.1.2.1. Risks of Side Effects
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Flavonoids*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.2.3. Daidzein
- 6.2.4. Genistein
- 6.2.5. Glycitein
- 6.2.6. Biochanin A
- 6.2.7. Coumestans
- 6.2.8. Prenyl Flavonoids
6.3. Lignans
6.4. Stilbenes
6.5. Others

7. By Source

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 7.1.2. Market Attractiveness Index, By Source
7.2. Soy Extract*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Nuts & Oilseeds
7.4. Cereals & Bread
7.5. Legumes
7.6. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Food & Beverages*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Nutraceuticals
8.4. Cosmetics
8.5. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals & Clinics*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Wellness Centers
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Omron Corporation *
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio
  - 12.1.2.1. Product Description
  - 12.1.2.2. Product Key Performance Indicators (KPIs)
  - 12.1.2.3. Historic and Forecasted Product Sales
  - 12.1.2.4. Product Sales Volume
- 12.1.3. Financial Overview
  - 12.1.3.1. Company Revenue's
  - 12.1.3.2. Geographical Revenue Shares
  - 12.1.3.3. Revenue Forecasts
- 12.1.4. Key Developments
  - 12.1.4.1. Mergers & Acquisitions
  - 12.1.4.2. Key Product Development Activities
  - 12.1.4.3. Regulatory Approvals etc.
- 12.1.5. SWOT Analysis
12.2. DoTERRA
12.3. Nutra Green
12.4. NATURAL ORGANICS INC.
12.5. Solaray
12.6. Archer Daniels Midland Company
12.7. Nature's Way
12.8. Deltastar
12.9. A.Vogel